7 Prostate Cancer Headlines You Can’t Miss

6. Prostate Cancer Blood Test, APIFINY, Being Promoted in US by Aeterna Zentaris APIFINY blood test Aeterna Zentaris Inc. announced it has begun promoting  APIFINY, the only non-PSA blood test for the evaluation of prostate cancer risk, in the U.S. under a co-marketing agreement with Armune BioScience, Inc. Under the agreement, Zentaris will promote APIFINY to designated medical professionals in 20 American territories, and receive a commission for each test that results from its promotion, the company says in its press release. Read more about it: http://bit.ly/1SgD3Az
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *